Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE is a synthetic organic compound belonging to the benzophenone class. It features a ketone group attached to two phenyl rings, one of which is substituted with hydroxyl groups at positions 3 and 4 and a nitro group at position 2. The molecular formula is C13H9NO5 and its molecular weight is approximately 259.21 g/mol[1][2][6]. This compound has been studied as an experimental small molecule inhibitor of catechol O-methyltransferase (COMT), an enzyme involved in the metabolism of catecholamines such as dopamine[3]. There are no approved medical indications or marketed formulations for this compound; it remains primarily a research tool.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 3,4-dihydroxy-2-nitrophenyl)(phenyl)methanone.